Obesity as an important risk factor for certain types of cancer

Iranian Journal of Cancer Prevention

Volumn 6, Issue 4, 2013, Pages 186-194

  Davoodi, Sayed Hossain ^a   Malek Shahabi, Talieh ^a   Malekshahi Moghadam, Ali ^b   Shahbazi, Roghieh ^a   Esmaeili, Saeideh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Adipocyte; Adipokines; Adiponectin; Neoplasms; Obesity

Indexed keywords

ADIPONECTIN; INTERLEUKIN 6; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL CONSUMPTION; BREAST CANCER; BROWN ADIPOSE TISSUE; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; COLORECTAL CANCER; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ENVIRONMENTAL FACTOR; GLUCOSE METABOLISM; HUMAN; INFECTION; KIDNEY CARCINOMA; LIPID METABOLISM; NUTRITION; OBESITY; PANCREAS CANCER; PHYSICAL INACTIVITY; POLLUTANT; PROSTATE CANCER; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; SUN EXPOSURE; WHITE ADIPOSE TISSUE;

EID: 84888405498     PISSN: 20082401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Chial H. Genetic regulation of cancer. Nature Education. 2008.
2. Pan MH, Ghai G, Ho CT. Food bioactive, apoptosis and cancer. Mol Nutr Food Res. 2008; 52(1): 43-52.
3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100: 57-70.
4. La Vecchia C, Negri E, D'Avanzo B, Boyle P, Franceschi S. Dietary indicators of oral and pharyngeal cancer. Int J Epidemiol. 1991; 20(1): 39-44.
5. Davoodi SH, Esmaeili S, Mortazavian AM. Effects of milk and milk products consumption on cancer: A Review. Compr Rev Food Sci Food Safety. 2013; 12(3): 249-264.
6. Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011; 11 (12): 886-895.
7. Marti A, Moreno-Aliaga MJ, Hebebrand J, Martínez JA. Genes, lifestyles and obesity. Int J Obes Relat Metab Disord. 2004; 28 (Suppl 3): 29-36.
8. John PH, Wilding DM. Causes of obesity. Practical Diabetes Int. 2001; 18(8): 288-292.
9. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303 (3): 235-241.
10. Finucane M, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011; 377 (9765): 557-567.
11. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008; 371 (9612): 569-578.
12. Jeffreys M, Smith GD, Martin RM, Frankel S, Gunnell D. Childhood body mass index and later cancer risk: a 50-year follow-up of the Boyd Orr study. Int J Cancer. 2004; 112 (2): 348-351.
13. Bjorndal B, Burri L, Staalesen V, Skorve J, Berge RK. Different Adipose Depots: Their Role in the Development of Metabolic Syndrome and Mitochondrial Response to Hypolipidemic Agents. J Obes. 2011; 2011: 490-650.
14. Shen W, Wang Z, Punyanita M, Lei J, Sinav A, Kral JG, et al. Adipose tissue quantification by imaging methods a proposed classification.Adipose tissue as an endocrine and paracrine organ. Obes Res. 2003; 11(1): 5-16.
15. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998; 22(12):1145-1158.
16. Fajn JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm. 2006;74: 443-477.
17. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112 (12): 1796-1808.
18. Ruan H, Zarnowski MJ, Cushman SW, Lodish HF. Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes. J Biol Chem. 2003; 278 (48): 47585-93.
19. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140 (6): 883-899.
20. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA. 1975; 72 (9): 3666-3670.
21. Leibovich, SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha. Nature. 1987; 329 (6140): 630-632.
22. Orosz P, Echtenacher, Falk W, Ruschoff J, Weber D, Mannel DN. Enhancement of experimental metastasis by tumor necrosis factor. J Exp Med. 1993; 177 (5): 1391-1398.
23. Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest. 2008; 118 (2): 560-570.
24. Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med. 1999; 5 (7): 828-31.
25. Knight BB, Yeoh GCT, Husk KL, Ly T, Abraham LJ, Yu C, et al. Impaired pre neoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med. 2000; 192 (12): 1809-1818.
26. Jain SS, Bird RP. Elevated expression of tumor necrosis factor-alpha signaling molecules in colonic tumors of Zucker obese (fa/fa) rats. Int J Cancer. 2010; 127 (9): 2042-2050.
27. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinal Metab. 2001; 280: E745-E751.
28. Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, et al. Dietary and genetic obesity promote liver inflammation and tumor genesis by enhancing IL-6 and TNF expression. Cell. 2010; 140 (2): 197-208.
29. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Sci. 2007; 317 (5834): 121-4.
30. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinal Metab. 1998; 83 (3): 847-850.
31. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinal Metab. 2001; 280: 745-751.
32. Mohamed-Ali V, Goodrich S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor- alpha, in vivo. J Clin Endocrinal Metab. 1997; 82(12): 4196-4200.
33. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, et al. Stat3 as an oncogene. Cell. 1999; 98 (3): 295-303.
34. Dano K, Behrendt N, Hoyer-Hansen G, Johnsen M, Lund LR, Ploug M, et al. Plasminogen activation and cancer. Thromb Hemost. 2005; 93(4): 76-681.
35. Ferrara N. Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action. Mol Biol Cell. 2010; 21 (5): 687-690.
36. Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell. 2010; 18 (6): 884-901.
37. Sawdey MS, Loskutoff, DJ. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J Clin Invest. 1991; 88 (4): 1346-1353.
38. Foekens JA, Schmitt M, Putten WLV, Peters HA, Kramer MD, Janicke F, et al. Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. J Clin Oncol. 1994; 12 (8): 1648-1658.
39. Mutoh M, Niho N, Komiya M, Takahashi M, Ohtsubo R, Nakatogawa K, et al. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min. mice. Carcinog. 2008; 29 (4): 824-829.
40. Cohen P, Zhao C, Cai X, Montez JM, Rohani SC, Feinstein P, et al. Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest. 2001; 108 (8): 1113-1121.
41. Jarde T, Perrier S, Vasson M P, Caldefie-Chezet F. Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer. 2011; 47 (1): 33-43.
42. Snoussi K, Storsberg AD, Bouaouina N, Ben Ahmed S, Helal AN, Chouchane L. Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer. 2006; 6: 38.
43. Howard JM, Pidgeon GP, Reynolds JV. Leptin and gastro-intestinal malignancies. Obes Rev. 2010; 11 (12): 863-874.
44. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995; 1 (11): 1155-1161.
45. Lagiou P, Signorello LB, Trichopoulos D, Taonou A, Mantzoros CS. Leptin in relation to prostate cancer and benign prostatic hyperplasia. Int J Cancer. 1998; 76 (1): 25-28.
46. Stattin P, Soderberg S, Hallmans G, Bylund A, Kaaks R, Stenman U, et al. Leptin is associated with increased prostate cancer risk: a nested case-referent study. J Clin Endocrinol Metab. 2001; 86 (3): 1341-1345.
47. Mantzoros CS, Bolhke K, Moschos S, Cramer DW. Leptin in relation to carcinoma in situ of the breast: a study of pre-menopausal cases and controls. Int J Cancer. 1999; 80 (4): 523-526.
48. Tamakoshi K, Toyoshima H, Wakai K, Kojima M, Suzuki K, Watanabe Y, et al. Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in Japan. Oncol. 2005; 68 (4-6): 454-461.
49. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP. Leptin is a growth factor for colonic epithelial cells. Gastroenterol. 2001; 121 (1): 79-90.
50. Dieudonne MN, Machinal-Quelin F, Seazin-leroy V, Leneveu MC, Pecquery R, Giudicelli Y. Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Common. 2002; 293 (1): 622-628.
51. Onuma M, Bub JD, Rummel TL, Iwamoto Y. Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. J Biol Chem. 2003 (43); 278: 42660-42667.
52. Choi JH, Park SH, Leung PC, Choi KC. Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. J Clin Endocrinol Metab. 2005; 90 (1): 207-210.
53. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene deregulated in obesity. J Biol Chem. 1996; 271 (18): 10697-10703.
54. Tworoger SS, Heater Eliassen A, Kelesidis T, Colditz GA, Willet WC, Mantzoros CS, et al. Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab. 2007; 92 (4): 1510-1516.
55. Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Lukanova A, et al. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab. 2007; 92 (1): 255-263.
56. Soliman PT, Cui X, Zhang Q, Hankinson SE, Lu KH. Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses' Health Study. Am J Obstet Gynecol. 2011; 204 (2): 167 e1-e5.
57. Kaklamani VG, Wisinski KB, Sadim M, Gulden C, Do A, Offit K, et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA. 2008; 300 (1): 1523-1531.
58. Hill HA, Austin H. Nutrition and Endometrial Cancer. Cancer Cause Control. 1996; 7 (1): 19-32.
59. Tornberg SA, Carstensen JM. Relationship Between Quetelet's Index and Cancer of Breast and Female Genital Tract in 47,000 Women followed for 25 Years. Br J Cancer. 1994; 69 (2): 358-361.
60. Senz-chavez TL, Vilar-compte D, De nicola-Delfin L, Meneses-Garsia A. Overweight, obesity, diabetes, and hypertension in endometrial cancer. Rev Med Inst Mex Seguro Soc. 2013; 51 (3): 326-329.
61. Ortiz-Mendoza CM, Velasco-Navarro C. Obesity, a main risk factor for endometrial cancer. Rev Med Inst Mex Seguro Soc. 2013; 51 (3): 260-263.
62. Key TJ. Hormones and Cancer in Humans. Mutat Res. 1995; 333 (1-2): 59-67.
63. Folsom AR, Kaye SA, Potter JD, Prineas RJ. Association of Incident Carcinoma of the Endometrium with Body Weight and Fat Distribution in Older Women. Early Findings of the Iowa Women's Health Study. Cancer Res. 1989; 49 (23): 6828-6831.
64. MacDonald PC, Siiteri PK. The Relationship Between the Extra glandular Production of Estrone and the Occurrence of Endometrial Neoplasia. Gynecol Oncol. 1974; 2 (2-3): 259-263.
65. MacInnis RJ, English DR. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Cause Control. 2006; 17 (8): 989-1003.
66. Andersson SO, Wolk A, Bergelström R, Adami HO, Engholm G, Englund A, Nyrén O. Body Size and Prostate Cancer: A 20-year Follow-up Study Among 135,006 Swedish Construction Workers. J Nat Cancer Inst. 1997; 89 (5): 385-388
67. Severson RK, Grove JS, Nomura AMY, Stemmerman GN. Body Mass and Prostatic Cancer: a Prospective Study. Br Med J. 1988; 297 (6650): 713-715.
68. Daniell HW. A Better Prognosis for Obese Men with Prostate Cancer. J Urol. 1996; 155 (1): 220-225.
69. Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer. 2007; 120 (9): 1993-1998.
70. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, et al. Body Mass Index and Risk, Age of Onset, and Survival in Patients with Pancreatic Cancer. AMA. 2009; 301 (24): 2553-2562.
71. Bracci PM. Obesity and pancreatic cancer: overview of epidemiologic evidence and1 biologic mechanisms. Mol carcinog. 2012; 51 (1): 53-63.
72. Wang J, Zhang W, Sun L, Yu H, Ni QX, Risch HA, et al. Dietary Energy Density Is Positively Associated with Risk of Pancreatic Cancer in urban Shanshai Chinese. J Nutr. 2013; 143.
73. Ziegler RG, Hoover RN, Nomura AMY, West DW, Wu AH, Fike MC, et al. Relative Weight,Weight Change, Height, and Breast Cancer Risk in Asian-American Women. J Nat Cancer Inst. 1996; 88 (10): 650-660.
74. Pathak DR, Whittemore AS. Combined Effects of Body Size, Parity, and Menstrual Events on Breast Cancer In- cidence in Seven Countries. Am J Epidemiol. 1992; 135 (2): 153-168.
75. Ballard-Barbash R. Anthropometry and Breast Cancer. Body Size-A Moving Target. Cancer. 1994; 74 (3suppl): 1090-100.
76. Schapira DV, Clark RA, Wolff PA, Jarrett AR, Kumar NB, Aziz NM. Visceral Obesity and Breast Cancer Risk. Cancer. 1994; 74 (2): 632-639.
77. Zhang S, Folsom AR, Sellers TA, Kushi L, and Potter JD. Better Breast Cancer Survival for Postmenopausal Women Who Are Less Overweight and Eat Less Fat. The Iowa Women's Health Study. Cancer. 1995; 76 (2): 275-283.
78. Siiteri PK. Adipose Tissue as a Source of Hormones. Am J Clin Nutr. 1987; 45 (1suppl): 277-282.
79. Russo J, Rivera B, Russo IH. Influence of Age and Parity on the Development of the Human Breasts. Breast Cancer Res Treat. 1992; 23 (3): 211-218.
80. Gunter MJ, Leitzmann MF. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J.Nutr Biochem. 2005; 17 (3): 145-156.
81. Potter JD. Nutrition and Colorectal Cancer. Cancer Causes Control. 1996; 7 (1): 127-46.
82. Phillips RL, Snowdon DA. Dietary Relationships with Fatal Colorectal Cancer Among Seventh-Day Adventists. J Nat Cancer Inst. 1985; 74 (2): 307-317.
83. Giovannuci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, and Willett WC. Physical Activity,Obesity, and Risk for Colon Cancer and Adenoma in Men. Ann Int Med. 1995; 122 (5): 327-334.
84. Slattery ML, Potter J, Caen B, Edwards S, Coates A, Ma KN, et al. Energy Balance and Colon Cancer- Beyond Physical Activity. Cancer Res. 1997; 57 (1): 75-80.
85. Carroll KK. Obesity as a Risk Factor for Certain Types of Cancer. Lipids. 1998; 33 (11): 1055-1059.
86. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol. 2006; 176 (6 Pt 1): 2353-2358.
87. Haggstrom C, Rapp K, Stocks T, Manger J, Bjorge T, Ulmer H, et al. Metabolic factors associated with risk of renal cell carcinoma. PLoS One. 2013; 8 (2): e57475.
88. Waalkes S, Mersenburger AS, Karmer MW, Herrmann TRW, Wegener G, Rustemeier J, et al. Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer. Cancer Cause Control. 2010; 21 (11): 1905-1910.
89. Wolk A, Lindblad P, Adami HO. Nutrition and Renal Cell Cancer. Cancer Cause Control. 1996; 7 (1): 5-18.